Exane Derivatives’s OR Royalties Inc OR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$192 Hold
19
﹤0.01% 677
2022
Q1
$251 Sell
19
-23,649
-100% -$294K ﹤0.01% 938
2021
Q4
$290K Sell
23,668
-709
-3% -$8.64K 0.07% 266
2021
Q3
$274K Buy
24,377
+7,278
+43% +$91.1K 0.07% 311
2021
Q2
$230K Buy
+17,099
New +$229K 0.05% 362
2018
Q3
Sell
-95,000
Closed -$893K 721
2018
Q2
$893K Buy
95,000
+8,000
+9% +$79K 0.15% 133
2018
Q1
$829K Buy
87,000
+4,000
+5% +$42.2K 0.17% 131
2017
Q4
$961K Buy
83,000
+12,000
+17% +$146K 0.17% 104
2017
Q3
$919K Buy
+71,000
New +$918K 0.17% 89

Other funds holding OR

Exane Derivatives's OR Position: Q2 2022 in Review

Exane Derivatives held its OR Royalties Inc (OR) position steady in Q2 2022 at 19 shares worth $192. The position accounts for ﹤0.01% of the portfolio, ranked #677.

Exane Derivatives first reported a position in OR in Q3 2017 and has held it in 9 quarters since. The position peaked at $961K in Q4 2017. 153 funds tracked by Wall St. Rank hold OR as of Q2 2022.

  • Exane Derivatives held 19 shares of OR Royalties Inc worth $192 as of Q2 2022.
  • Exane Derivatives left its OR Royalties Inc share count unchanged in Q2 2022.
  • OR Royalties Inc made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #677 holding.
  • Exane Derivatives first reported a position in OR Royalties Inc in Q3 2017 and has held it in 9 quarters since.
  • Exane Derivatives's OR Royalties Inc position peaked at $961K in Q4 2017.
  • 153 funds tracked by Wall St. Rank held OR Royalties Inc as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.